Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACER: Cisplatin in TNBC Not Achieving Clinical CR After AC
NCT02001519Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Mar 2012
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in triple-negative breast cancer (TNBC), sponsored by Asan Medical Center. Started Mar 2012; status: completed.
02
Drugs
cisplatin
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT02001519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02001519.